Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypertriglyceridaemia: Therapeutic Targets, Genetic Causes, and Associated Neuropathy

NCT02195050 is registered in ClinicalTrials.gov with Manchester University NHS Foundation Trust as lead sponsor.

NCT NCT02195050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02195050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypertriglyceridaemia: Therapeutic Targets, Genetic Causes, and Associated Neuropathy
Lead sponsor
Manchester University NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
January 23, 2014
Completion date
December 31, 2030
Enrollment
1,396 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridaemia